Well, the answer is with the Pfizer Inc. According to Pfizer, Chantix, the first new prescription medication approved for smoking cessation in nearly a decade, received priority review designation by the U.S. Food and Drug Administration (FDA) because of its potential to be a significant therapeutic advance over existing therapies.
Why do smokers get the habitual kick of this deadly ?
Any addiction for that matter is hard to kickass. However, we all smokers ought to do this as soon as possible and kiss an early death bye-bye!
When smokers inhale smoke from a cigarette, nicotine reaches the brain within seconds and binds to nicotinic receptors, which activates the reward pathway in brain circuitry. This stimulates the pleasure center in the brain. The initial effects recede quickly and a cycle of craving and withdrawal takes hold.
and live life to its fullest!
Chantix is simply unique because it does not let you go off the habit in one go, as that could lead to serious withdrawal symptoms in the body. Chantix is unique for the reason that is slowly helps to bring the cravings down, ultimately leading you to a smoke-free life. This drug is specifically designed to partially activate the nicotinic receptor and reduce the severity of the smoker's craving and the withdrawal symptoms from nicotine. Moreover, if a person smokes a cigarette while receiving treatment, Chantix has the potential to diminish the sense of satisfaction associated with smoking. This may help to prevent the cycle of nicotine addiction.
Nicotine addiction-a statistic shocker!
According to Dr. Cheryl Oncken, a Chantix clinical investigator and associate professor of Medicine at the University of Connecticut Health Center. "It is never too late to quit smoking. People who quit smoking before the age of 50 have one- half the risk of dying of a smoking-related illness in the next 15 years compared to those who continue smoking. Patients who are unable to quit on their own should consider seeking medical support and treatment."
Conclusion
According to Karen Katen, Pfizer vice chairman and president of Pfizer Human Health, "It takes about 10 attempts -- with or without treatment -- before the average smoker is able to quit."
